Nur Çınar-Şirin

Nur Çınar-Şirin

Auto-generated profile, based on publicly available information

Nur Çınar-Şirin

Department of Medical Biochemistry, Faculty of Medicine , Istanbul Arel University , Istanbul , Türkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2025 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
YOYıldız Oner-Iyidogan
Yıldız Oner-Iyidogan
NÇNur Çınar-Şirin
Nur Çınar-Şirin
SASelda Can Arkaya
Selda Can Arkaya
PEPınar Kural Enç
Pınar Kural Enç
Objectives: This study aimed to investigate serum fetuin-A (FetA) and adiponectin levels, the FetA/adiponectin ratio (FAR), and their roles in inflammation and insulin resistance in overweight individuals. Instead of evaluating FAR as a predictive biomarker, this study aimed to explore its association with metabolic parameters in this population. Materials: The study included 57 participants aged 24–56 years, divided into control (BMI<25 kg/m 2 , n=27) and overweight (BMI 25–30 kg/m 2 , n=30) groups. Anthropometric measurements and body composition analyses were performed after a 12-h fasting period. Serum FetA, adiponectin, progranulin, and CTRP-3 levels were measured using ELISA. Insulin resistance was assessed using the HOMA-IR index. Statistical analyses included Mann–Whitney U tests, correlation analyses, and ROC curve analysis. Results: Overweight individuals showed significantly higher waist circumference, body fat mass, and HOMA-IR compared to controls, while adiponectin levels were significantly lower (p=0.006). The FAR was elevated in the overweight group (p=0.023) and positively correlated with BMI, body fat mass, and HOMA-IR (p<0.05). Progranulin and CTRP-3 levels showed no significant differences between groups, but a negative correlation between these two adipokines was observed. ROC analysis revealed an optimal FAR cut-off of 40.5 for predicting increased BMI, with 60 % sensitivity and 80 % specificity. Conclusions: The findings suggest that FAR is associated with insulin resistance and metabolic parameters in overweight individuals. Although promising, its clinical utility as a diagnostic biomarker requires further investigation.